Question

Could the examination of psychedelic interpretations across women and men aid understanding of biological/developmental/cultural sex differences? Could it empower both sexes to know more about this?

Why I quit microdosing

Published in Human Parts

1_Wg3hpA1MDRHbn_aodlDFNg
Illustration by @magic.theatre.studio/Instagram

Switching gears along the Yarra River, I pedal faster and faster, heading nowhere in particular. My face just crashed into a party of flies and now I’m swallowing wings. Sinking into my surroundings — the wind, ripples in the water, parrots overhead — with no thoughts of all the elses and elsewheres I could be, I’m tripping.

This microdose feels like a half tab. Which isn’t necessarily bad, except I can’t focus. I can’t sit still. I can’t read the lines of a book without being bombarded by my own. I can’t write. All I can do is keep going and going. Moving through. This is not what I anticipated for a Wednesday morning. Continue reading “Why I quit microdosing”

Dosing after microdosing

Moving from psychedelic routine to spot-treatment, originally published on Medium

Screen Shot 2019-03-04 at 2.06.50 PM
Kristina Johnson

Fifteen micrograms of acid, on a sliver of paper, washed down with a glass of water. This is my medicine of choice.

*

I microdosed 1P-LSD from April to December 2017 following a regimen: one day on, threeish days off. It’s been over a year since I stopped that routine and tapered my dosing to as-needed for mood support.

Eight months is a bit longer than most ~microdosing experts~ recommend. Online sources typically suggest six weeks or three months, but that’s mostly speculative. Any recommendations for continued psychedelic use (and all psychiatric medicine?) are relatively inexpert given our still premature understanding of the brain. When it comes to intimate psychological issues, there is no single cure for what has complex—and largely unknown—causes. No one knows which precise treatment or prescription will work for anyone. Especially in people with discreet or hard-to-diagnose issues, who experience difficulty communicating, or who are especially young or old. It’s all an experiment. That’s what the medical community has been doing, as well as a few rogue individuals.

Testing, and reflecting. Continue reading “Dosing after microdosing”

Bioethics topics to explore

Migration as a bioethics issue — not allowing people to migrate physically (from asylum seeking to relocation for better opportunity and simply travel) and mentally (with psychoactive substance or mind-altering experiences) is a bioethics issue. Regulations on migration, travel, and drug use serve some and harm many.

The ethics of psychiatric diagnosis/prescription vs. self-medication — the current psychiatric system also serves some, but hurts many, and moving from the doctor-patient power imbalance to patient empowerment could be a solution. This research would seek information about people who do not receive psychiatric treatment (for reasons from ability to financial), who do not benefit from current pharmaceuticals, and who already know which drugs they want to try — whether from their psychiatrist or from the street. Do you know people who go to the doctor knowing what they’ll be asking for? Isn’t this doctor-approved self-medication? Do you know people given drugs by doctors that they wouldn’t take on their own, that might even make them seem worse? (Thinking strictly re: psychiatric medicine, not for example, cancer treatment.) Is self-medication really the problem authorities should fight or should they provide wider education and harm reduction instead? Reference: Portugal. Will the information age cut out doctors as the middle men between patients and their preferred medicine?  This would reference Our Right to Drugs by Thomas Szasz, among others.